Back to Search
CHARU TRIVEDI, MD
MD
Hematology & Oncology Physician
NPI: 1386641397IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35078923T(OH)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1988
Research & Publications (15)
Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma.
PMID 10918176·Cancer·2000
3-trial
Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation.
PMID 18830417·J Clin Invest·2008
7-preclinical
Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy.
PMID 18625706·J Biol Chem·2008
7-preclinical
Differential regulation of HOXA9 expression by nuclear factor kappa B (NF-kappaB) and HOXA9.
PMID 18068911·Gene·2008
8-other
Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium.
PMID 17586512·Atherosclerosis·2007
8-other
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.
PMID 17322895·Nat Med·2007
7-preclinical
Effect of atorvastatin treatment on isoproterenol-induced myocardial infarction in rats.
PMID 16567950·Pharmacology·2006
7-preclinical
Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
PMID 16168716·Vascul Pharmacol·2005
7-preclinical
Pseudodiarrhea caused by vaginal pessary in an elderly patient.
PMID 15935050·J Am Geriatr Soc·2005
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 STEWART RD, SUITE B
MONROE, MI 48162 - Phone
- (734) 242-7902
Quick Facts
- NPI
- 1386641397
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 38
- Publications
- 15
Are you this provider?
Claim Your Profile